Initiation and propagation of α-synuclein aggregation in the nervous system

被引:0
|
作者
Baraa A. Hijaz
Laura A. Volpicelli-Daley
机构
[1] University of Alabama at Birmingham,Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics
关键词
Parkinson’s disease; α-Synuclein; Amyloid; Fibril; Oligomer; Lewy body; Neurodegeneration;
D O I
暂无
中图分类号
学科分类号
摘要
The two main pathological hallmarks of Parkinson’s disease are loss of dopamine neurons in the substantia nigra pars compacta and proteinaceous amyloid fibrils composed mostly of α-synuclein, called Lewy pathology. Levodopa to enhance dopaminergic transmission remains one of the most effective treatment for alleviating the motor symptoms of Parkinson’s disease (Olanow, Mov Disord 34:812–815, 2019). In addition, deep brain stimulation (Bronstein et al., Arch Neurol 68:165, 2011) to modulate basal ganglia circuit activity successfully alleviates some motor symptoms. MRI guided focused ultrasound in the subthalamic nucleus is a promising therapeutic strategy as well (Martinez-Fernandez et al., Lancet Neurol 17:54–63, 2018). However, to date, there exists no treatment that stops the progression of this disease. The findings that α-synuclein can be released from neurons and inherited through interconnected neural networks opened the door for discovering novel treatment strategies to prevent the formation and spread of Lewy pathology with the goal of halting PD in its tracks. This hypothesis is based on discoveries that pathologic aggregates of α-synuclein induce the endogenous α-synuclein protein to adopt a similar pathologic conformation, and is thus self-propagating. Phase I clinical trials are currently ongoing to test treatments such as immunotherapy to prevent the neuron to neuron spread of extracellular aggregates. Although tremendous progress has been made in understanding how Lewy pathology forms and spreads throughout the brain, cell intrinsic factors also play a critical role in the formation of pathologic α-synuclein, such as mechanisms that increase endogenous α-synuclein levels, selective expression profiles in distinct neuron subtypes, mutations and altered function of proteins involved in α-synuclein synthesis and degradation, and oxidative stress. Strategies that prevent the formation of pathologic α-synuclein should consider extracellular release and propagation, as well as neuron intrinsic mechanisms.
引用
收藏
相关论文
共 50 条
  • [21] α-Synuclein aggregation and Parkinson's disease:: Factors affecting the aggregation of α-synuclein
    Jin, L
    Yang, H
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2006, 33 (04) : 321 - 328
  • [22] Age-dependent aggregation of α-synuclein in the nervous system of gut-brain axis is associated with caspase-1 activation
    Qi Hu
    Mei Hong
    Mengyang Huang
    Quan Gong
    Xiaofan Zhang
    Vladimir N. Uversky
    Francisco Pan-Montojo
    Teng Huang
    Honglian Zhou
    Suiqiang Zhu
    [J]. Metabolic Brain Disease, 2022, 37 : 1669 - 1681
  • [23] Age-dependent aggregation of α-synuclein in the nervous system of gut-brain axis is associated with caspase-1 activation
    Hu, Qi
    Hong, Mei
    Huang, Mengyang
    Gong, Quan
    Zhang, Xiaofan
    Uversky, Vladimir N.
    Pan-Montojo, Francisco
    Huang, Teng
    Zhou, Honglian
    Zhu, Suiqiang
    [J]. METABOLIC BRAIN DISEASE, 2022, 37 (05) : 1669 - 1681
  • [24] Gut dysfunction may be the source of pathological aggregation of alpha-synuclein in the central nervous system through Paraquat exposure in mice
    Wang, Kaidong
    Zhang, Chunhui
    Zhang, Baofu
    Li, Guoliang
    Shi, Ge
    Cai, Qian
    Huang, Min
    [J]. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2022, 246
  • [25] Acceleration of α-synuclein aggregation
    Gaspar, Ricardo
    Meisl, Georg
    Buell, Alexander K.
    Young, Laurence
    Kaminski, Clemens F.
    Knowles, Tuomas P. J.
    Sparr, Emma
    Linse, Sara
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 20 - 21
  • [26] NERVOUS SYSTEM OF HYDRA .3. INITIATION OF SEXUALITY WITH SPECIAL REFERENCE TO NERVOUS SYSTEM
    BURNETT, AL
    DIEHL, NA
    [J]. JOURNAL OF EXPERIMENTAL ZOOLOGY, 1964, 157 (02): : 237 - &
  • [27] Monitoring α-synuclein aggregation
    Estaun-Panzano, Juan
    Arotcarena, Marie-Laure
    Bezard, Erwan
    [J]. NEUROBIOLOGY OF DISEASE, 2023, 176
  • [28] Assays for α-synuclein aggregation
    Giehm, Lise
    Lorenzen, Nikolai
    Otzen, Daniel E.
    [J]. METHODS, 2011, 53 (03) : 295 - 305
  • [29] The aggregation and fibrillation of α-synuclein
    Fink, Anthony L.
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (09) : 628 - 634
  • [30] Monitoring a-synuclein Aggregation Induced by Preformed a-synuclein Fibrils in an In Vitro Model System
    Kim, Beom Jin
    Noh, Hye Rin
    Jeon, Hyongjun
    Park, Sang Myun
    [J]. EXPERIMENTAL NEUROBIOLOGY, 2023, 32 (03) : 147 - 156